For the past 35 years, Children’s Miracle Network (CMN) has provided critical funding to support clinical and research initiatives to advance the margin of excellence for our pediatric patients.
In conjunction with Children’s Hospital leadership, CMN has hosted a competitive grant process each year to fund emerging and ongoing clinical and research initiatives. For the current fiscal year, CMN provided $1.3 million in research and $1.9 million in clinical support.
After a thorough process review by key stakeholders, the CMN clinical allocation process will change beginning in FY21.
- CMN will fulfill its commitments to previously funded, time-limited positions.
- CMN will no longer accept direct requests for capital support. All requests should be submitted through the institution’s formal Capital Request Process.
- An executive team has been formed that will annually review and agree upon key clinical activities or capital initiatives that CMN funding will support. The executive team may also identify a strategic initiative(s) per year to receive CMN funding.
- Depending upon available funds, the executive team may choose to put forward a call for proposals to support clinical requests. This option will not be available for the FY21 funding cycle but may resume for FY22.
Information regarding the new clinical allocation process and its implementation may be found online at CMNHershey.org/Funding. Key clinical activities identified by the executive team to receive funding for FY21 will be posted to this site on Friday, Dec. 6.
The new CMN clinical allocation process will have no impact on the current CMN Research Allocation Process, and a call for proposals will be released later this fall.
For immediate questions or concerns, please contact CMNApplications@pennstatehealth.psu.edu.